In vitro evaluation of iron solubility and dialyzability of various iron fortificants and of iron-fortified milk products targeted for infants and toddlers

International Journal of Food Sciences and Nutrition

Volumn 56, Issue 4, 2005, Pages 293-302

  Kapsokefalou, Maria ^a   Alexandropoulou, Isidora ^a   Komaitis, Michail ^a   Politis, Ioannis ^a  

^a AGRICULTURAL UNIVERSITY OF ATHENS   (Greece)

Author keywords

Infants; Iron bioavailability; Milk processing; Toddlers

Indexed keywords

ASCORBIC ACID; FERROUS DIGLYCINATE; FERROUS GLUCONATE; FERROUS LACTATE; FERROUS SULFATE; IRON; IRON DERIVATIVE; IRON PYROPHOSPHATE; MINERAL; UNCLASSIFIED DRUG; VITAMIN;

ARTICLE; BIOAVAILABILITY; CHILD NUTRITION; COMPARATIVE STUDY; DAIRY PRODUCT; DIET SUPPLEMENTATION; GASTROINTESTINAL TRACT; GREECE; HUMAN; IN VITRO STUDY; INFANT; IRON INTAKE; IRON THERAPY; MILK HYGIENE; MILK PRODUCTION; MOLECULAR WEIGHT; PASTEURIZATION; PREDICTION; SIMULATION; SOLUBILITY;

ANIMALS; BIOLOGICAL AVAILABILITY; CHILD, PRESCHOOL; DIALYSIS; FERROUS COMPOUNDS; FOOD HANDLING; FOOD, FORTIFIED; HUMANS; INFANT; INFANT FOOD; IRON; LACTATES; MILK; MINERALS; SOLUBILITY; VITAMINS;

EID: 23344453495     PISSN: 09637486     EISSN: None     Source Type: Journal    
DOI: 10.1080/09637480500146515     Document Type: Article

References (24)

1. Ait-Oukhatar N, Peres JM, Bouhallab S, Neuville D, Bureau F, Bouvard G, Arhan P, Bougle D.. 2002. Bioavailability of caseinophosphopeptide-bound iron. J Lab Clin Med 140:290-294.
2. Anonymous. 1999. Iron fortification of infant formulas. American Academy of Pediatrics. Committee on Nutrition. Pediatrics 104(1 Part 1):119-123.
3. Boccio JR, Zubillaga MB, Caro RA, Gotelli CA, Gotelli MJ, Weill R. 1996. Bioavailability and stability of microencapsulated ferrous sulfate in fluid milk:studies in mice. J Nutr Sci Vitaminol (Tokyo) 42:233-239.
4. Brise H, Hallberg L. 1962. Absorbability of different iron compounds. Acta Med Scand 171:23-37.
5. Centers for Disease Control and Prevention. 1998. Recommendations to prevent and control iron deficiency in the United States. MMWR 47 (No. RR-3). Atlanta: U.S. Department of Health and Human Services.
6. Cunniff P. 1999. AOAC official method 984.27. In: AOAC International. Official methods of analysis of AOAC International. 16th ed. Gaitherburg, MD: AOAC International. pp 15-16.
7. Fidler MC, Walczyk T, Davidsson L, Zeder C, Sakaguch Ni, Juneja LR, Hurrell RF. 2004. A micronised, dispersible ferric pyrophosphate with high relative bioavailability in man. Br J Nutr 91:107-112.
8. Forbes AL, Adams CE, Arnaud MJ, Chichester CO, Cook JD, Harrison MN, Hurrell RF, Kahn SG, Morris ER, Tanner JT, et al. 1989. Comparison of In vitro, animal, and clinical determinations of iron bioavailability: international and nutritional anemia consultative group task force report on iron bioavailability. Am J Clin Nutr 49:225-238.
9. Glahn RP, Van Campen DR. 1997. Iron uptake is enhanced in Caco-2 cell monolayers by cysteine and reduced cysteinyl glycine. J Nutr 127:642-647.
10. Hazell T, Johnson IT. 1987. In vitro estimation of iron bioavailability from a range of plant foods: influence of phytate, ascorbate and citrate. Br J Nutr 57:223-233.
11. Hendricks GM, Guo MP, Kindstedt PS. 2001. Solubility and relative absorption of copper, iron and zinc in two milk-based infant formulas. Int J Food Sci Nutr 52:419-428.
12. Hurrell R. 2002. Fortification: overcoming technical and practical barriers. J Nutr 132:806S-812S.
13. Hurrell RF, Lynch SR, Trinidad TP, Dassenko SA, Cook JD. 1989. Iron absorption in humans as influenced by bovine milk proteins. Am J Clin Nutr 43:546-552.
14. Kapsokefalou M, Miller DD. 1991. Effects of meat and selected food components on the valence of nonheme iron during In vitro digestion. J Food Sci 56:352-355, 358.
15. Lynch SR, Stoltzfus RJ. 2003. Iron and ascorbic acid: proposed fortification levels and recommended iron compounds. J Nutr 133:2978S-2984S.
16. Lysionek A, Zubillaga M, Salgueiro J, Caro R, Ettlin E, Boccio J. 2001. Bioavailability studies of a new iron source by means of the prophylactic-preventive method in rats. Biol Trace Elem Res 84:123-128.
17. Miller DD, Berner LA. 1989. Is solubility In vitro a reliable predictor of iron bioavailability? Biol Trace Elem Res 19:11-24.
18. Olivares M, Pizarro F, Pineda O, Name JJ, Hertrampf E, Walter T. 1997. Milk inhibits and ascorbic acid favors ferrous bis-glycine chelate bioavailability in humans. J Nutr 127:1407-1411.
19. Reddy MB, Chidambaram MV, Fonseca J, Bates GW. 1986. Potential role of In vitro iron bioavailability studies in combating iron deficiency: a study of the effects of phosvitin on iron mobilization from pinto beans. Clin Physiol Biochem 4:78-86.
20. Sakaguchi N, Rao TP, Nakata K, Nanbu H, Juneja LR. 2004. Iron absorption and bioavailability in rats of micronized dispersible ferric pyrophosphate. Int J Vitam Nutr Res 74:3-9.
21. Schricker BR, Miller DD, Rasmussen RR, Van Campen D. 1981. A comparison of in vivo and In vitro methods for determining availability of iron from meals. Am J Clin Nutr 34:3357-3363.
22. Whittaker P, Spivey Fox MR, Forbes AL. 1989. In vitro prediction of iron bioavailability for food fortification. Nutr Rep Int 39:1205-1210.
23. Yeung AC, Glahn RP, Miller DD. 2002. Effects of iron source on iron availability from casein and casein phosphopeptides. J Food Sci 67:1271-1275.
24. Zar JH. 1999. Multiple comparisons. In: Biostatistical analysis. Upper Saddle River, NJ: Prentice Hall, Inc. pp 208-230.